logo

For the Inventor, By the Inventor

Chapel Hill, NC, United States of America

Kenneth F Bastow

This inventor holds 15 USPTO granted patents and 2 published patent applications. Top assignees: The University of North Carolina at Chapel Hill, National Taiwan University, Other. Active years: 1995-2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kenneth F Bastow. Retrieved from https://idiyas.com/inventor/kenneth-f-bastow

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 15 

% Patents Active = 40.0

Average Co-Inventor Count = 3.6

ph-index = 4

Forward Citations = 83(Granted Patents)


Company Filing History:

goldMedal13 out of 1,327 
 
The University of North Carolina at Chapel Hill
 patents
silverMedal1 out of 1,392 
 
National Taiwan University
 patents
bronzeMedal2 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1995-2015

Loading Chart...
15 patents (USPTO):Explore Patents
1. 9216977 - Antofine and cryptopleurine derivatives as anticancer agents (2015-12-22),
2. 8188089 - Tylophorine analogs as antitumor agents (2012-05-29),
3. 7795299 - Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents (2010-09-14),
4. 7671088 - Water-soluble etoposide analogs and methods of use thereof (2010-03-02),
5. 7495026 - Neo-tanshinlactone and analogs as potent and selective anti-breast cancer agents (2009-02-24),
6. 7176236 - Water-soluble etoposide analogs and methods of use thereof (2007-02-13),
7. 6916831 - Flavone acetic acid analogs and methods of use thereof (2005-07-12),
8. 6872841 - Etoposide analogs and methods of use thereof (2005-03-29),
9. 6624317 - Taxoid conjugates as antimitotic and antitumor agents (2003-09-23),
10. 6593334 - Camptothecin-taxoid conjugates as antimitotic and antitumor agents (2003-07-15),
11. 6566393 - Etoposide analogs and methods of use thereof (2003-05-20),
12. 6420377 - Covalent conjugates of topoisomerase I and topoisomerase II inhibitors (2002-07-16),
13. 6207673 - Covalent conjugates of topoisomerase I and topoisomerase II inhibitors (2001-03-27),
14. 5639793 - Mammalian DNA topoisomerase II inhibitor and method (1997-06-17),
15. 5426224 - Mammalian DNA topoisomerase II inhibitor and method (1995-06-20),

Title: Innovations and Contributions of Kenneth F. Bastow

Introduction

Kenneth F. Bastow is a notable inventor based in Chapel Hill, NC (US), recognized for his significant contributions to the field of cancer treatment. With a total of 15 patents to his name, he has made remarkable strides in developing innovative compounds aimed at combating cancer.

Latest Patents

Among his latest patents are "Antofine and cryptopleurine derivatives as anticancer agents," which provides compounds of Formula (I-IV) and methods for their use in cancer treatment. Another significant patent is "Tylophorine analogs as antitumor agents," which describes compounds of Formula I and their pharmaceutical applications in treating cancer. These inventions highlight his commitment to advancing medical science and improving patient outcomes.

Career Highlights

Kenneth has worked at the University of North Carolina at Chapel Hill, where he has contributed to various research initiatives. His work has been instrumental in the development of new therapeutic agents that have the potential to change the landscape of cancer treatment.

Collaborations

Throughout his career, Kenneth has collaborated with esteemed colleagues such as Kuo-Hsiung Lee and Zhiyan Xiao. These partnerships have fostered a collaborative environment that enhances innovation and research in the field.

Conclusion

Kenneth F. Bastow's contributions to cancer research through his patents and collaborations underscore his role as a leading inventor in the medical field. His work continues to inspire advancements in cancer treatment and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…